- UroToday Home
- Recent Abstracts
- Urologic Oncology
Prostate Cancer
Body-mass index, prostate cancer-specific mortality and biochemical recurrence:A systematic review and meta-analysis - Abstract
February 17, 2011
Targeted delivery of a cisplatin prodrug for safer and more effective prostate cancer therapy in vivo - Abstract
February 17, 2011
Urinary and sexual disorders following localised prostate cancer management - Abstract
February 16, 2011
Focal therapy in the management of localized prostate cancer - Abstract
February 16, 2011
Long-term outcome in patients with a Gleason score ≤ 6 prostate cancer treated by radical prostatectomy - Abstract
February 16, 2011
Determining prostate cancer-specific death through quantification of stromogenic carcinoma area in prostatectomy specimens - Abstract
February 16, 2011
Long-term survival after radical prostatectomy versus external-beam radiotherapy for patients with high-risk prostate cancer - Abstract
February 16, 2011
Prostate-derived Ets transcription factor (PDEF) is a potential prognostic marker in patients with prostate cancer - Abstract
February 16, 2011
Editor's Commentary - Pilot study of salvage laparoscopic prostatectomy for the treatment of recurrent prostate cancer
February 16, 2011
Recent developments in prostate cancer biomarker research: Therapeutic implications - Abstract
February 15, 2011
High-risk clinically localised prostate cancer - Abstract
February 15, 2011
Battling prostate cancer with 5-alpha-reductase inhibitors: A Pyrrhic victory? - Abstract
February 15, 2011